SCHEMBL8551772

SCHEMBL8551772

Cn1ccc(/C=C/[N+](=O)[O-])n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 11/20 0.42
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 3/20 0.39
EGFR P00533 1/20 0.38
VCP P55072 2/20 0.38
HSP90AA1 P07900 2/20 0.37
MAPK1 P28482 2/20 0.36
HTT P42858 2/20 0.36
MITF O75030 1/20 0.36
NTSR1 P30989 1/20 0.36
MC4R P32245 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8638984 1.00 FBP1 (0.42) FBP1HDAC1HDAC2ALDH1A1MAPT
SCHEMBL25420528 0.78 ALDH1A1 (0.40) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL25420525 0.78 ALDH1A1 (0.40) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL25607555 0.76 FBP1 (0.38) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL25607689 0.74 FBP1 (0.36) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL25607634 0.74 FBP1 (0.36) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL8551495 0.73 FBP1 (0.47) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL8642464 0.73 FBP1 (0.47) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL28994128 0.73 FBP1 (0.39) FBP1ALDH1A1MAPTSMN1; SMN2LMNA
SCHEMBL22708167 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed
US-20230167119-A1 DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST Bugworks Research, Inc. 2023-06-01 US disclosed
CN-115867553-A Diaminopyrazolo [1,5-a ] pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonists 巴格沃克斯研究有限公司 2023-03-28 CN disclosed
EP-0833630-A4 NOVEL BENZOPYRAN COMPOUNDS AND METHODS FOR THEIR USE SUGEN INC (US) 1998-09-02 EP disclosed
US-5763470-A Benzopyran compounds and methods for their use SUGEN INC. (US) 1998-06-09 US disclosed
EP-0833630-A1 NOVEL BENZOPYRAN COMPOUNDS AND METHODS FOR THEIR USE Sugen, Inc. (US) 1998-04-08 EP disclosed
WO-1996040110-A1 NOVEL BENZOPYRAN COMPOUNDS AND METHODS FOR THEIR USE SUGEN, INC. (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS FBP1 2279/4885HDAC1 2810/4885HDAC2 3592/4885
US-20230167119-A1 DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST ADORA2A, ADORA2B, ADORA1 FBP1 964/4885HDAC1 3993/4885HDAC2 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.